Mary Culnane
Overview
Explore the profile of Mary Culnane including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
313
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Watts D, Huang S, Culnane M, Kaiser K, Scheuerle A, Mofenson L, et al.
J Perinat Med
. 2010 Dec;
39(2):163-70.
PMID: 21142844
Objective: To determine rate of and risk factors for birth defects in infants born to HIV-infected women receiving nucleoside and protease inhibitor antiretroviral (ARV) therapy. Methods: Birth defects were evaluated...
2.
Chalermchockcharoenkit A, Culnane M, Chotpitayasunondh T, Vanprapa N, Leelawiwat W, Mock P, et al.
Clin Infect Dis
. 2009 Jun;
49(2):299-305.
PMID: 19522656
Background: World Health Organization guidelines for prevention of mother-to-child transmission of human immunodeficiency virus type 1 (HIV-1) recommend administration of zidovudine and single-dose nevirapine (NVP) for HIV-1-infected women who are...
3.
Bhanich Supapol W, Remis R, Raboud J, Millson M, Tappero J, Kaul R, et al.
J Infect Dis
. 2008 Apr;
197(10):1369-77.
PMID: 18419578
Background: Prolonged coinfection with GB virus C (GBV-C) has been associated with improved survival in human immunodeficiency virus (HIV)-infected adults. We investigated whether maternal or infant GBV-C infection was associated...
4.
Chokephaibulkit K, Chotpitayasunondh T, Vanprapar N, Waranawat N, Mock P, McConnell M, et al.
Clin Infect Dis
. 2007 Sep;
45(8):1016-8.
PMID: 17879918
We evaluated local reactions at 1, 2, and 4 months of age to bacille Calmette-Guérin vaccine given at birth to 1058 infants who were exposed to human immunodeficiency virus (HIV)....
5.
Plipat T, Naiwatanakul T, Rattanasuporn N, Sangwanloy O, Amornwichet P, Teeraratkul A, et al.
AIDS
. 2007 Jan;
21(2):145-51.
PMID: 17197804
Background: In 2000, Thailand implemented a national program to prevent mother-to-child HIV transmission (PMTCT). Objective: To describe the effectiveness of the prevention of mother-to-child HIV transmission program in Thailand. Design...
6.
Bollen L, Chuachoowong R, Kilmarx P, Mock P, Culnane M, Skunodom N, et al.
Sex Transm Dis
. 2006 Feb;
33(4):259-64.
PMID: 16452834
Background: Human immunodeficiency virus (HIV)-infected women are at increased risk for developing cervical cancer and for infection with human papillomavirus (HPV). Prophylactic vaccines targeting HPV types 16 and 18 are...
7.
Teeraratkul A, Simonds R, Asavapiriyanont S, Chalermchokcharoenkit A, Vanprapa N, Chotpitayasunondh T, et al.
J Acquir Immune Defic Syndr
. 2005 Jan;
38(2):208-12.
PMID: 15671807
The 2 largest maternity hospitals in Bangkok implemented comprehensive programs to prevent mother-to-child HIV transmission in 1998. We conducted a cross-sectional survey of post-partum HIV-infected women in 1999 through 2001...
8.
Watts D, Balasubramanian R, Maupin Jr R, Delke I, Dorenbaum A, Fiore S, et al.
Am J Obstet Gynecol
. 2004 Feb;
190(2):506-16.
PMID: 14981398
Objective: The purpose of this study was to evaluate rates of maternal toxicity, pregnancy complications, and peripartum morbidity by type and duration of antiretroviral therapy (ART) during pregnancy. Study Design:...
9.
Mirochnick M, Dorenbaum A, Blanchard S, Cunningham C, Gelber R, Mofenson L, et al.
J Acquir Immune Defic Syndr
. 2003 Jun;
33(2):153-6.
PMID: 12794547
Objective: To evaluate cord blood and predose nevirapine concentrations in infants exposed to the two-dose intrapartum neonatal nevirapine regimen. Methods: The authors obtained plasma samples for nevirapine assay from cord...
10.
Mirochnick M, Dorenbaum A, Holland D, Cunningham C, Gelber R, Mofenson L, et al.
Pediatr Infect Dis J
. 2002 Sep;
21(9):835-8.
PMID: 12352805
Objective: To determine the concentrations of protease inhibitors in cord blood after prenatal protease inhibitor use by pregnant women. Design: Retrospective analysis of samples collected in a clinical trial. Methods:...